Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07181135 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

FINE-START: Efficacy and Safety of Finerenone in Patients With Chronic Kidney Disease Not Using Renin-angiotensin-system Inhibitors

Study acronym: FINE-START
StatusEnrolling by Invitation
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Start date: Mar 23, 2026 to Mar 13, 2026v4
  2. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date changed from estimate of Dec 1, 2025 to Mar 23, 2026 · Study sites: 0 to 8v3 Show 2 more changesShow less
    • Start date changed from estimate of Dec 1, 2025 to Mar 23, 2026
    • Study sites: 0 to 8
  3. Study description revisedv2 See this version in full on ClinicalTrials.gov ↗
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Study to demonstrate efficacy of finerenone when compared to placebo in reducing albuminuria in participants with chronic kidney disease (CKD) not using renin-angiotensin-system (RAS) inhibitors.
Trial Details
NCT Number NCT07181135
Lead Sponsor University Medical Center Groningen
Conditions Chronic Kidney Disease
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov